Drug Master Files for: ATRACURIUM BESYLATE
✉ Email this page to a colleague
ATRACURIUM BESYLATE Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 11144 | I | II | 10/21/1994 | ABBOTT LABORATORIES | ATRACURIUM BESYLATE |
| 11607 | A | II | 7/31/1995 | FARMHISPANIA SA | ATRACURIUM BESYLATE USP |
| 11742 | A | II | 11/14/1995 | TEVA PHARMACEUTICAL INDUSTRIES LTD | ATRACURIUM BESYLATE |
| 12120 | I | II | 9/5/1996 | QUIMICA ESTEROIDAL SA DE CV | ATRACURIUM BESYLATE |
| 18444 | I | II | 6/21/2005 | CF PHARMA LTD | ATRACURIUM BESYLATE |
| 21189 | A | II | 12/3/2007 | GLAND PHARMA LTD | ATRACURIUM BESYLATE USP |
| 22962 | A | II | 7/21/2009 | GLAND PHARMA LTD | CISATRACURIUM BESYLATE |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
